June 2, 2020
NKMax America Receives FDA Clearance of IND for Phase I/2a Trial of their Natural Killer Cell Therapy (SNK01) in Combination with Trastuzumab or Cetuximab for the Treatment of Advanced/Metastatic HER2- or EGFR- Expressing Cancers
SANTA ANA, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development ...
May 29, 2020
NKMax America Presents Promising Clinical Research Findings at 2020 ASCO Virtual Conference
SANTA ANA, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development ...
April 30, 2020
NKMax America To Present Data from its Natural Killer Cell Immunotherapy Clinical Program at the ASCO20 Virtual Scientific Program
SANTA ANA, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development ...
April 30, 2020
Recce Pharmaceuticals Announces First-Quarter 2020 Financial Results and Provides Operational Highlights
SYDNEY, Australia, April 29, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the company developing a new class of broad-spectrum synthetic antibiotics, today ...
April 30, 2020
Celyad to Present Update from CYAD-101 for Advanced Colorectal Cancer and Next-Generation shRNA Platform at 2020 ASCO Virtual Scientific Program
MONT-SAINT-GUIBERT, Belgium, April 30, 2020 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
April 30, 2020
BioInvent Signs New Manufacturing Agreement With U.S. Cell Therapy Company
LUND, Sweden, April 30, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and ...
April 30, 2020
Palatin Technologies Provides Assessment of Impact of COVID-19 Pandemic on Business Operations
CRANBURY, N.J., April 30, 2020 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...
April 30, 2020
Ziopharm Oncology Announces Poster Presentations at the 2020 American Society of Clinical Oncology Virtual Meeting
BOSTON, April 30, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (ZIOP), today announced that it will be presenting data from its Controlled IL-12 program, or ...
April 30, 2020
Immunomedics to Report First Quarter 2020 Results and Host Conference Call and Webcast On May 6, 2020
MORRIS PLAINS, N.J., April 30, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug ...
April 30, 2020
Vaxart Announces Additional Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program
SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet ...
April 30, 2020
AzurRx BioPharma Receives Insititutional Review Board Approval to Commence its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis
NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) --  AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies ...
April 30, 2020
Paratek Pharmaceuticals to Report First Quarter 2020 Financial Results on May 11, 2020
BOSTON, April 30, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies ...
April 30, 2020
Check-Cap Ltd. Announces $4.5 Million Registered Direct Offering
ISFIYA, Israel, April 30, 2020 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...
April 30, 2020
CohBar to Announce 2020 First Quarter Financial Results and Provide Business Update on May 14, 2020
MENLO PARK, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases ...
April 30, 2020
Albireo to Report First Quarter 2020 Financial Results on May 7
BOSTON, April 30, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
April 30, 2020
AB Science reports today its annual financials as of 31 December 2019
AB Science SA (NYSE Euronext - FR0010557264 - AB) reports today its annual financials as of 31 December 2019 and provides an update on its ...
April 30, 2020
Vermillion to Report First Quarter 2020 Financial Results on May 14
AUSTIN, Texas, April 30, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will ...
April 30, 2020
Chiasma To Report First Quarter Financial Results On May 7, 2020
NEEDHAM, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients with rare ...
April 30, 2020
Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park Capital
NEWTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
April 30, 2020
Inspire Medical Systems, Inc. to Present at the BofA Securities Virtual Health Care Conference 2020
MINNEAPOLIS, April 30, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...
Page 1 of 202